Tirzepatide and semaglutide: different twins?
Abstract
This comparative analysis is crucial for clinicians, as it underscores the importance of a personalized approach when integrating these powerful incretin therapies into patient care. Understanding the distinct advantages of Tirzepatide (superior weight loss, insulin sensitivity) versus Semaglutide (established cardiovascular/renal benefits) allows for optimized treatment strategies.